Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9JZO

Crystal structure of PHICD111_20024_EAD.

Summary for 9JZO
Entry DOI10.2210/pdb9jzo/pdb
DescriptorEndolysine, ZINC ION (3 entities in total)
Functional Keywordsantibiotic, endolysin
Biological sourceClostridium phage phiCD111
Total number of polymer chains2
Total formula weight38374.65
Authors
Hwang, J.S.,Seo, M.D. (deposition date: 2024-10-14, release date: 2025-09-24)
Primary citationPark, J.,Yoo, S.,An, J.,Cho, Y.,Park, K.,Hwang, J.,Chun, S.I.,Kang, N.J.,Seo, M.D.,Yoon, H.
In vitro characterization of PHICD111_20024_EAD as an engineered endolysin against Clostridioides difficile.
J Glob Antimicrob Resist, 45:1-10, 2025
Cited by
PubMed Abstract: Clostridioides difficile is a Gram-positive, spore-forming obligate anaerobe that can cause symptoms such as diarrhoea and abdominal cramping and lead to conditions including pseudomembranous colitis. The mainstay treatment of C. difficile infection (CDI) is antibiotics; however, antibiotics-induced gut microbiota dysbiosis poses a potential risk for refractory CDI and increased CDI recurrences. Recently, there has been growing interest in bacteriophages and their lytic enzymes as alternatives to antibiotics. We aimed to develop an engineered endolysin to specifically inactivate C. difficile.
PubMed: 40845944
DOI: 10.1016/j.jgar.2025.08.009
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.4 Å)
Structure validation

248636

PDB entries from 2026-02-04

PDB statisticsPDBj update infoContact PDBjnumon